Six peptides including BPC-157 and TB-500 won advisory panel votes, but Martin notes compounding them stays unlawful until the FDA finalizes the bulks list.
Recap by typeshit. Full story at Drug Topics.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
An investor take on Lilly's pipeline. One stat stands out: Lilly said 80% of Foundayo prescriptions went to people new to GLP-1 drugs.
A GoodRx roundup of newer weight loss medications. Only the title came through, so tap through for the full list and details.
Loading…